These results suggested that upregulated DRG TET1 and TRPV4 expression may be the cause of allodynia in rats with bone cancer pain and that allodynia may be reversed by pharmacologically inhibiting TET1 and TRPV4 activity. Here, TRPV4 is linked to bone neoplasm.